Featured Articles

PAREXEL International Corporation announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea. The collaboration is designed to provide…
Read More...

Boehringer Ingelheim and Vanderbilt University announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research…
Read More...

Illumina asserted the appointment of Dr. Phil Febbo who is a Leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be…
Read More...

Connexient which is the healthcare leader in enterprise digital wayfinding , mapping and indoor navigation services set to roll out enhanced software version, MediNav Navigator 3.0.…
Read More...

BioVentrix announced successful treatment of the first patient at the Cardiovascular Institute of the South in the ALIVE pivotal clinical trial. The trial is designed to demonstrate the…
Read More...

MYR Pharma GmbH asserted the completion of MYR 202 Clinical Trial which is a Phase 2b study investigating Myrcludex B in chronic hepatitis Delta patients which is a more acute form of…
Read More...

When compared to medical therapies, a bariatric surgeon and an endocrinologist specializing in diabetes observed that the effectiveness of medical versus surgical intervention proved to…
Read More...

Intec Pharma asserted that it has partnered with LTS Lohmann Therapie-Systeme AG for manufacturing Company's lead candidate, Accordion Pill Carbidopa/Levodopa (AP-CD/LD) as a treatment…
Read More...

Paramount comprehensive liquid biopsy, Guardant360 assay to be utilized as sole liquid biopsy in LC-SCRUM-Japan which is a nationwide genomic screening network run by the National…
Read More...

Pfizer declared optimistic outcome from U.S FDA's Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.  The  GIDAC met to discuss Pfizer’s supplemental New Drug Application (sNDA…
Read More...

In order to help ensure more affordable and timely access to patients whose medical needs are unmet , Regeneron Pharmaceuticals and Sanofi will offer payers that agree to lessen…
Read More...

Royal Philips which is a global leader in health technology claimed health economic results from DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio…
Read More...

The Janssen Pharmaceutical Companies of Johnson and Johnson announced results of new analysis exhibiting that INVOKANA remarkably lessened the risk of cardiovascular death or…
Read More...

Eyenuk which is a leading developer of advanced artificial intelligence enabled clinically supported solutions to identify diseases via retinal image analysis declared that it has…
Read More...

TherapeuticsMD which is an innovative women's healthcare company claimed the FDA's admission of NDA for TX-001HR. TX-001HR is the company’s investigational bio-identical hormone therapy…
Read More...

Tyber Medical which is a privately held company emphasizing on developing breakthrough medical devices for private label opportunities and facilitating  the science  of bioengineered…
Read More...

Roche declared that its new hematology testing solution, the cobas m 511 integrated hematology analyzer has received 510(k) clearance from the U.S Food and Drug Administration. The…
Read More...

According to the newly published research in Molecular and Cellular Proteomics describes a biomarker panel based on patient IgM antibodies that can certainly distinguish between Zika…
Read More...

Biotech company based in Dayton,OH has received IRB approval to initiate a Clinical case series studying spinal cord stimulator alogrithms in patients afflicted with back pain.…
Read More...

CrossRoads Extremity Systems which is privately held medical device company offering innovative foot & ankle fixation implant systems and services asserted that it has recently…
Read More...